株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医薬品開発業務受託機関 (CRO) の世界市場:産業分析、地域別の見通し、成長可能性、市場シェア、予測

Contract Research Organization Market Size By Service Type, By Therapeutic Area, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024

発行 Global Market Insights Inc. 商品コード 756454
出版日 ページ情報 英文 210 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.36円で換算しております。
Back to Top
医薬品開発業務受託機関 (CRO) の世界市場:産業分析、地域別の見通し、成長可能性、市場シェア、予測 Contract Research Organization Market Size By Service Type, By Therapeutic Area, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024
出版日: 2018年11月22日 ページ情報: 英文 210 Pages
概要

当レポートでは、世界の医薬品開発業務受託機関 (CRO) 市場について調査分析し、産業の考察、セグメント別の市場分析、地域別の分析、主要企業など、体系的な情報を提供しています。

第1章 調査手法・範囲

第2章 エグゼクティブサマリー

第3章 医薬品開発業務受託機関 (CRO) :産業の考察

  • 産業区分
  • 産業情勢
  • 産業の影響要因
  • 成長可能性の分析
  • 規制情勢
  • ポーターのファイブフォース分析
  • 競合情勢
  • PESTEL分析

第4章 医薬品開発業務受託機関 (CRO) 市場:サービスタイプ別

  • 主なセグメントの動向
  • 医薬品初期開発サービス
  • 臨床研究サービス
  • ラボサービス
  • コンサルティングサービス

第5章 医薬品開発業務受託機関 (CRO) 市場:治療領域別

  • 主なセグメントの動向
  • 臨床薬理
  • 心臓
  • 感染症
  • 神経
  • 胃腸病 & 肝臓病
  • 眼科
  • その他

第6章 医薬品開発業務受託機関 (CRO) 市場:エンドユーズ別

  • 主なセグメントの動向
  • 医薬品 & バイオ医薬品企業
  • 医療機器企業
  • 大学機関

第7章 医薬品開発業務受託機関 (CRO) 市場:地域別

  • 主なセグメントの動向
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 企業プロファイル

  • Charles River Laboratories International, Inc. (CRL)
  • Clinipace
  • Clinitec
  • CMIC Holdings Co., Ltd
  • EPS International
  • ICON Public Limited Corporation
  • Laboratory Corporation of America Holdings (Covance Inc.)
  • Medpace, Inc.
  • Parexel International Corporation
  • Pharmaceutical Product Development (PDD), LLC.
  • PRA Health Sciences
  • IQVIA (Quintiles IMS Holdings, Inc.)
  • Syneos Health
  • Synteract
  • Worldwide Clinical Trials
  • Wuxi AppTec
図表

Data Tables

  • TABLE 1: CRO industry 360 degree synopsis, 2013 - 2024
  • TABLE 2: CRO, 2013-2017 (USD Million)
  • TABLE 3: CRO market, 2018-2024 (USD Million)
  • TABLE 4: CRO market, by service type, 2013-2017 (USD Million)
  • TABLE 5: CRO market, by service type, 2018-2024 (USD Million)
  • TABLE 6: CRO market, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 7: CRO market, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 8: CRO market, by end-use, 2013-2017 (USD Million)
  • TABLE 9: CRO market, by end-use, 2018-2024 (USD Million)
  • TABLE 10: CRO market, by region, 2013-2017 (USD Million)
  • TABLE 11: CRO market, by region, 2018-2024 (USD Million)
  • TABLE 12: Industry impact forces
  • TABLE 13: Early phase development services market size, by region, 2013-2017 (USD Million)
  • TABLE 14: Early phase development services market size, by region, 2018-2024 (USD Million)
  • TABLE 15: Discovery services market size, by region, 2013-2017 (USD Million)
  • TABLE 16: Discovery services market size, by region, 2018-2024 (USD Million)
  • TABLE 17: CMC market size, by region, 2013-2017 (USD Million)
  • TABLE 18: CMC market size, by region, 2018-2024 (USD Million)
  • TABLE 19: Pre-clinical services market size, by region, 2013-2017 (USD Million)
  • TABLE 20: Pre-clinical services market size, by region, 2018-2024 (USD Million)
  • TABLE 21: PK/PD market size, by region, 2013-2017 (USD Million)
  • TABLE 22: PK/PD market size, by region, 2018-2024 (USD Million)
  • TABLE 23: Toxicology testing services market size, by region, 2013-2017 (USD Million)
  • TABLE 24: Toxicology testing services market size, by region, 2018-2024 (USD Million)
  • TABLE 25: Others market size, by region, 2013-2017 (USD Million)
  • TABLE 26: Others market size, by region, 2018-2024 (USD Million)
  • TABLE 27: Clinical research services market size, by region, 2013-2017 (USD Million)
  • TABLE 28: Clinical research services market size, by region, 2018-2024 (USD Million)
  • TABLE 29: Phase I market size, by region, 2013-2017 (USD Million)
  • TABLE 30: Phase I market size, by region, 2018-2024 (USD Million)
  • TABLE 31: Phase II market size, by region, 2013-2017 (USD Million)
  • TABLE 32: Phase II market size, by region, 2018-2024 (USD Million)
  • TABLE 33: Phase III market size, by region, 2013-2017 (USD Million)
  • TABLE 34: Phase III market size, by region, 2018-2024 (USD Million)
  • TABLE 35: Phase IV market size, by region, 2013-2017 (USD Million)
  • TABLE 36: Phase IV market size, by region, 2018-2024 (USD Million)
  • TABLE 37: Laboratory services market size, by region, 2013-2017 (USD Million)
  • TABLE 38: Laboratory services market size, by region, 2018-2024 (USD Million)
  • TABLE 39: Bioanalytical testing services market size, by region, 2013-2017 (USD Million)
  • TABLE 40: Bioanalytical testing services market size, by region, 2018-2024 (USD Million)
  • TABLE 41: Analytical testing services market size, by region, 2013-2017 (USD Million)
  • TABLE 42: Analytical testing services market size, by region, 2018-2024 (USD Million)
  • TABLE 43: Physical characterization market size, by region, 2013-2017 (USD Million)
  • TABLE 44: Physical characterization market size, by region, 2018-2024 (USD Million)
  • TABLE 45: Raw material testing market size, by region, 2013-2017 (USD Million)
  • TABLE 46: Raw material testing market size, by region, 2018-2024 (USD Million)
  • TABLE 47: Batch release testing market size, by region, 2013-2017 (USD Million)
  • TABLE 48: Batch release testing market size, by region, 2018-2024 (USD Million)
  • TABLE 49: Stability testing market size, by region, 2013-2017 (USD Million)
  • TABLE 50: Stability testing market size, by region, 2018-2024 (USD Million)
  • TABLE 51: Others market size, by region, 2013-2017 (USD Million)
  • TABLE 52: Others market size, by region, 2018-2024 (USD Million)
  • TABLE 53: Consulting services market size, by region, 2013-2017 (USD Million)
  • TABLE 54: Consulting services market size, by region, 2018-2024 (USD Million)
  • TABLE 55: Oncology market size, by region, 2013-2017 (USD Million)
  • TABLE 56: Oncology market size, by region, 2018-2024 (USD Million)
  • TABLE 57: Clinical pharmacology market size, by region, 2013-2017 (USD Million)
  • TABLE 58: Clinical pharmacology market size, by region, 2018-2024 (USD Million)
  • TABLE 59: Cardiology market size, by region, 2013-2017 (USD Million)
  • TABLE 60: Cardiology market size, by region, 2018-2024 (USD Million)
  • TABLE 61: Infectious disease market size, by region, 2013-2017 (USD Million)
  • TABLE 62: Infectious disease market size, by region, 2018-2024 (USD Million)
  • TABLE 63: Neurology market size, by region, 2013-2017 (USD Million)
  • TABLE 64: Neurology market size, by region, 2018-2024 (USD Million)
  • TABLE 65: Gastroenterology & hepatology market size, by region, 2013-2017 (USD Million)
  • TABLE 66: Gastroenterology & hepatology market size, by region, 2018-2024 (USD Million)
  • TABLE 67: Ophthalmology market size, by region, 2013-2017 (USD Million)
  • TABLE 68: Ophthalmology market size, by region, 2018-2024 (USD Million)
  • TABLE 69: Others market size, by region, 2013-2017 (USD Million)
  • TABLE 70: Others market size, by region, 2018-2024 (USD Million)
  • TABLE 71: Pharmaceutical & biopharmaceutical companies market size, by region, 2013-2017 (USD Mn)
  • TABLE 72: Pharmaceutical & biopharmaceutical companies market size, by region, 2018-2024 (USD Mn)
  • TABLE 73: Medical device companies market size, by region, 2013-2017 (USD Million)
  • TABLE 74: Medical device companies market size, by region, 2018-2024 (USD Million)
  • TABLE 75: Academic institutes market size, by region, 2013-2017 (USD Million)
  • TABLE 76: Academic institutes market size, by region, 2018-2024 (USD Million)
  • TABLE 77: North America CRO market size, by country, 2013-2017 (USD Million)
  • TABLE 78: North America CRO market size, by country, 2018-2024 (USD Million)
  • TABLE 79: North America CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 80: North America CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 81: North America CRO market size, by early phase development services, 2013-2017 (USD Mn)
  • TABLE 82: North America CRO market size, by early phase development services, 2018-2024 (USD Mn)
  • TABLE 83: North America CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 84: North America CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 85: North America CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 86: North America CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 87: North America CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 88: North America CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 89: North America CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 90: North America CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 91: North America CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 92: North America CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 93: North America CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 94: North America CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 95: U.S. CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 96: U.S. CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 97: U.S. CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 98: U.S. CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 99: U.S. CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 100: U.S. CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 101: U.S. CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 102: U.S. CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 103: U.S. CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 104: U.S. CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 105: U.S. CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 106: U.S. CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 107: U.S. CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 108: U.S. CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 109: U.S. CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 110: U.S. CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 111: Canada CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 112: Canada CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 113: Canada CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 114: Canada CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 115: Canada CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 116: Canada CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 117: Canada CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 118: Canada CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 119: Canada CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 120: Canada CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 121: Canada CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 122: Canada CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 123: Canada CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 124: Canada CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 125: Canada CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 126: Canada CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 127: Europe CRO market size, by country, 2013-2017 (USD Million)
  • TABLE 128: Europe CRO market size, by country, 2018-2024 (USD Million)
  • TABLE 129: Europe CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 130: Europe CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 131: Europe CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 132: Europe CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 133: Europe CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 134: Europe CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 135: Europe CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 136: Europe CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 137: Europe CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 138: Europe CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 139: Europe CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 140: Europe CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 141: Europe CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 142: Europe CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 143: Europe CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 144: Europe CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 145: Germany CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 146: Germany CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 147: Germany CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 148: Germany CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 149: Germany CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 150: Germany CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 151: Germany CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 152: Germany CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 153: Germany CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 154: Germany CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 155: Germany CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 156: Germany CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 157: Germany CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 158: Germany CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 159: Germany CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 160: Germany CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 161: France CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 162: France CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 163: France CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 164: France CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 165: France CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 166: France CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 167: France CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 168: France CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 169: France CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 170: France CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 171: France CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 172: France CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 173: France CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 174: France CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 175: France CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 176: France CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 177: UK CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 178: UK CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 179: UK CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 180: UK CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 181: UK CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 182: UK CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 183: UK CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 184: UK CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 185: UK CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 186: UK CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 187: UK CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 188: UK CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 189: UK CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 190: UK CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 191: UK CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 192: UK CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 193: Italy CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 194: Italy CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 195: Italy CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 196: Italy CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 197: Italy CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 198: Italy CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 199: Italy CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 200: Italy CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 201: Italy CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 202: Italy CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 203: Italy CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 204: Italy CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 205: Italy CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 206: Italy CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 207: Italy CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 208: Italy CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 209: Spain CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 210: Spain CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 211: Spain CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 212: Spain CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 213: Spain CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 214: Spain CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 215: Spain CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 216: Spain CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 217: Spain CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 218: Spain CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 219: Spain CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 220: Spain CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 221: Spain CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 222: Spain CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 223: Spain CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 224: Spain CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 225: Asia Pacific CRO market size, by country, 2013-2017 (USD Million)
  • TABLE 226: Asia Pacific CRO market size, by country, 2018-2024 (USD Million)
  • TABLE 227: Asia Pacific CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 228: Asia Pacific CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 229: Asia Pacific CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 230: Asia Pacific CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 231: Asia Pacific CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 232: Asia Pacific CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 233: Asia Pacific CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 234: Asia Pacific CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 235: Asia Pacific CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 236: Asia Pacific CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 237: Asia Pacific CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 238: Asia Pacific CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 239: Asia Pacific CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 240: Asia Pacific CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 241: Asia Pacific CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 242: Asia Pacific CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 243: Japan CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 244: Japan CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 245: Japan CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 246: Japan CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 247: Japan CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 248: Japan CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 249: Japan CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 250: Japan CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 251: Japan CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 252: Japan CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 253: Japan CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 254: Japan CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 255: Japan CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 256: Japan CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 257: Japan CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 258: Japan CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 259: India CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 260: India CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 261: India CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 262: India CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 263: India CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 264: India CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 265: India CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 266: India CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 267: India CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 268: India CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 269: India CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 270: India CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 271: India CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 272: India CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 273: India CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 274: India CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 275: China CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 276: China CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 277: China CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 278: China CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 279: China CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 280: China CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 281: China CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 282: China CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 283: China CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 284: China CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 285: China CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 286: China CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 287: China CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 288: China CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 289: China CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 290: China CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 291: Latin America CRO market size, by country, 2013-2017 (USD Million)
  • TABLE 292: Latin America CRO market size, by country, 2018-2024 (USD Million)
  • TABLE 293: Latin America CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 294: Latin America CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 295: Latin America CRO market size, by early phase development services, 2013-2017 (USD Mn)
  • TABLE 296: Latin America CRO market size, by early phase development services, 2018-2024 (USD Mn)
  • TABLE 297: Latin America CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 298: Latin America CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 299: Latin America CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 300: Latin America CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 301: Latin America CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 302: Latin America CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 303: Latin America CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 304: Latin America CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 305: Latin America CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 306: Latin America CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 307: Latin America CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 308: Latin America CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 309: Brazil CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 310: Brazil CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 311: Brazil CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 312: Brazil CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 313: Brazil CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 314: Brazil CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 315: Brazil CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 316: Brazil CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 317: Brazil CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 318: Brazil CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 319: Brazil CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 320: Brazil CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 321: Brazil CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 322: Brazil CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 323: Brazil CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 324: Brazil CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 325: Mexico CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 326: Mexico CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 327: Mexico CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 328: Mexico CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 329: Mexico CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 330: Mexico CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 331: Mexico CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 332: Mexico CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 333: Mexico CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 334: Mexico CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 335: Mexico CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 336: Mexico CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 337: Mexico CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 338: Mexico CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 339: Mexico CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 340: Mexico CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 341: MEA CRO market size, by country, 2013-2017 (USD Million)
  • TABLE 342: MEA CRO market size, by country, 2018-2024 (USD Million)
  • TABLE 343: MEA CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 344: MEA CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 345: MEA CRO market size, by early phase development services, 2013-2017 (USD Million)
  • TABLE 346: MEA CRO market size, by early phase development services, 2018-2024 (USD Million)
  • TABLE 347: MEA CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 348: MEA CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 349: MEA CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 350: MEA CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 351: MEA CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 352: MEA CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 353: MEA CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 354: MEA CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 355: MEA CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 356: MEA CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 357: MEA CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 358: MEA CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 359: Saudi Arabia CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 360: Saudi Arabia CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 361: Saudi Arabia CRO market size, by early phase development services, 2013-2017 (USD Mn)
  • TABLE 362: Saudi Arabia CRO market size, by early phase development services, 2018-2024 (USD Mn)
  • TABLE 363: Saudi Arabia CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 364: Saudi Arabia CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 365: Saudi Arabia CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 366: Saudi Arabia CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 367: Saudi Arabia CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 368: Saudi Arabia CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 369: Saudi Arabia CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 370: Saudi Arabia CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 371: Saudi Arabia CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 372: Saudi Arabia CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 373: Saudi Arabia CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 374: Saudi Arabia CRO market size, by end-use, 2018-2024 (USD Million)
  • TABLE 375: South Africa CRO market size, by service type, 2013-2017 (USD Million)
  • TABLE 376: South Africa CRO market size, by service type, 2018-2024 (USD Million)
  • TABLE 377: South Africa CRO market size, by early phase development services, 2013-2017 (USD Mn)
  • TABLE 378: South Africa CRO market size, by early phase development services, 2018-2024 (USD Mn)
  • TABLE 379: South Africa CRO market size, by pre-clinical services, 2013-2017 (USD Million)
  • TABLE 380: South Africa CRO market size, by pre-clinical services, 2018-2024 (USD Million)
  • TABLE 381: South Africa CRO market size, by clinical research services, 2013-2017 (USD Million)
  • TABLE 382: South Africa CRO market size, by clinical research services, 2018-2024 (USD Million)
  • TABLE 383: South Africa CRO market size, by laboratory services, 2013-2017 (USD Million)
  • TABLE 384: South Africa CRO market size, by laboratory services, 2018-2024 (USD Million)
  • TABLE 385: South Africa CRO market size, by analytical testing services, 2013-2017 (USD Million)
  • TABLE 386: South Africa CRO market size, by analytical testing services, 2018-2024 (USD Million)
  • TABLE 387: South Africa CRO market size, by therapeutic area, 2013-2017 (USD Million)
  • TABLE 388: South Africa CRO market size, by therapeutic area, 2018-2024 (USD Million)
  • TABLE 389: South Africa CRO market size, by end-use, 2013-2017 (USD Million)
  • TABLE 390: South Africa CRO market size, by end-use, 2018-2024 (USD Million)

Charts & Figures

  • FIG. 1: Industry segmentation
  • FIG. 2: Global CRO market, 2013 - 2024 (USD Million)
  • FIG. 3: Growth potential analysis, by service type
  • FIG. 4: Growth potential analysis, by therapeutic area
  • FIG. 5: Growth potential analysis, by end-use
  • FIG. 6: Porter's analysis
  • FIG. 7: Company market share analysis, 2017
  • FIG. 8: Strategy dashboard
  • FIG. 9: PESTEL Analysis
目次
Product Code: 3012

Title:
Contract Research Organization (CRO) Market Size By Service Type (Early Phase Development Services {Discovery Services, Chemistry, Manufacturing & Control (CMC), Pre-clinical Services [Pharmacokinetics/Pharmacodynamics (PK/PD), Toxicology Testing Services]}, Clinical Research Services {Phase I, Phase II, Phase III, Phase IV}, Laboratory Services {Bioanalytical Testing Services, Analytical Testing Services [Physical Characterization, Raw Material Testing, Batch Release Testing, Stability Testing]}, Consulting Services), By Therapeutic Area (Oncology, Clinical Pharmacology, Cardiology, Infectious Disease, Neurology, Gastroenterology & Hepatology, Ophthalmology), By End-use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, Japan, India, China, Brazil, Mexico, Saudi Arabia, South Africa), Application Potential, Competitive Market Share & Forecast, 2018 - 2024.

Contract Research Organization (CRO) Market will exceed USD 56.5 billion by 2024; as per a new research report.

Growing trend of technological advances coupled with pharmacovigilance outsourcing will drive the contract research organization market growth over the forecast timeline. Implementation of technologies such as patient recorded outcomes (PRO), clinical trial management systems (CTMS) and electronic data capture (EDC) further favors contract research organization industry growth. Regulations focusing on enhancing patient safety and quality management systems should boost CRO market growth over the coming years.

Rising prevalence of chronic ailments such as infectious diseases, cancer further fosters business growth. Larger commercialization of R&D in drug industry can boost productivity that should drive contract research organization (CRO) market. Moreover, increasing demand for global clinical trials and requirement for quality auditing will augment CRO industry growth. However, intellectual property issues surface at numerous points in technology transfer and institutional research that can restrain contract research organization (CRO) market growth.

Early phase development services segment was valued at USD 5.8 billion in 2017 and is projected to grow significantly over the forecast timeframe. The growth is attributable to increasing early research activities in drug discovery process coupled with rising outsourcing for early phase development.

Cardiology segment will witness 8.1% CAGR by 2024 due to growing prevalence of cardiovascular diseases and surging number of clinical trials in cardiology. According to American Heart Association 2018 data nearly 92.1 million American adults are having after effects of stroke or some type of cardiovascular disease (CVD). Indirect and direct costs of overall CVDs and stroke are projected to exceed USD 329.7 billion. Rising adoption of unhealthy eating habits and lack of physical exercises accelerate the prevalence of CVD that should further boost segmental growth in forthcoming years.

Academic institutes segment accounted for 16.5% revenue share in 2017 owing to growing number of outsourcing research activities to academic institutes. Rapidly developing research practices coupled with rising outsourcing of R&D activities should spur segmental growth in foreseeable future.

U.S. CRO market will grow at 7.3% during the forecast timeframe due to technological advances and wide-ranging drug development activities conducted in the country. Additionally, presence of several pharma companies in the U.S. should render positive impact on CRO industry.

China CRO market was valued at USD 1.3 billion in 2017 and is estimated to experience considerable growth over the coming years. The growth is attributable to fast approval procedures. Chinese firms pursue transparent and fast approval procedures through results that are acceptable to U.S. FDA thereby, fosters business growth.

Some of the prominent competitors operating in CRO market include: Charles River Laboratories International (CRL), Clinipace, Clinitec, CMIC, EPS International, ICON, Laboratory Corporation of America Holdings (Covance), Medpace, Parexel International, Pharmaceutical Product Development (PDD), LLC, PRA Health Sciences, IQVIA (Quintiles IMS), Syneos Health, Synteract, Worldwide Clinical Trials and Wuxi AppTec. Industry competitors are mainly focusing on inorganic strategies such as partnership, merger and acquisitions. Merger and acquisitions ensure cost savings in CRO operations. Additionally, it also strengthens their foothold in the CRO market and capture more revenue share.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Contract research organization industry 360 degree synopsis, 2013 - 2024
    • 2.1.1. Business trends
    • 2.1.2. Service type trends
    • 2.1.3. Therapeutic area trends
    • 2.1.4. End-use trends
    • 2.1.5. Regional trends

Chapter 3. Contract Research Organization Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2013 - 2024
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increasing R&D expenditure worldwide
      • 3.3.1.2. Rising number of clinical trials in emerging economies
      • 3.3.1.3. Growing outsourcing of R&D activities
      • 3.3.1.4. Rising technological advancements
    • 3.3.2. Industry pitfalls and challenges
      • 3.3.2.1. Intellectual property rights issues
  • 3.4. Growth potential analysis
    • 3.4.1. By service type
    • 3.4.2. By therapeutic area
    • 3.4.3. By end-use
  • 3.5. Regulatory landscape
  • 3.6. Porter's analysis
  • 3.7. Competitive landscape, 2017
    • 3.7.1. Company market share analysis, 2017
    • 3.7.2. Strategy dashboard
  • 3.8. PESTEL analysis

Chapter 4. Contract Research Organization Market, By Service Type

  • 4.1. Key segment trends
  • 4.2. Early phase development services
    • 4.2.1. Market size, by region, 2013 - 2024
    • 4.2.2. Discovery services
      • 4.2.2.1. Market size, by region, 2013 - 2024
    • 4.2.3. Chemistry, manufacturing & control (CMC)
      • 4.2.3.1. Market size, by region, 2013 - 2024
    • 4.2.4. Pre-clinical services
      • 4.2.4.1. Market size, by region, 2013 - 2024
      • 4.2.4.2. Pharmacokinetics/pharmacodynamics (PK/PD)
        • 4.2.4.2.1. Market size, by region, 2013 - 2024
      • 4.2.4.3. Toxicology testing services
        • 4.2.4.3.1. Market size, by region, 2013 - 2024
      • 4.2.4.4. Others
        • 4.2.4.4.1. Market size, by region, 2013 - 2024
  • 4.3. Clinical research services
    • 4.3.1. Market size, by region, 2013 - 2024
    • 4.3.2. Phase I
      • 4.3.2.1. Market size, by region, 2013 - 2024
    • 4.3.3. Phase II
      • 4.3.3.1. Market size, by region, 2013 - 2024
    • 4.3.4. Phase III
      • 4.3.4.1. Market size, by region, 2013 - 2024
    • 4.3.5. Phase IV
      • 4.3.5.1. Market size, by region, 2013 - 2024
  • 4.4. Laboratory services
    • 4.4.1. Market size, by region, 2013 - 2024
    • 4.4.2. Bioanalytical testing services
      • 4.4.2.1. Market size, by region, 2013 - 2024
    • 4.4.3. Analytical testing services
      • 4.4.3.1. Market size, by region, 2013 - 2024
      • 4.4.3.2. Physical characterization
        • 4.4.3.2.1. Market size, by region, 2013 - 2024
      • 4.4.3.3. Raw material testing
        • 4.4.3.3.1. Market size, by region, 2013 - 2024
      • 4.4.3.4. Batch release testing
        • 4.4.3.4.1. Market size, by region, 2013 - 2024
      • 4.4.3.5. Stability testing
        • 4.4.3.5.1. Market size, by region, 2013 - 2024
      • 4.4.3.6. Others
        • 4.4.3.6.1. Market size, by region, 2013 - 2024
  • 4.5. Consulting services
    • 4.5.1. Market size, by region, 2013 - 2024

Chapter 5. Contract Research Organization Market, By Therapeutic Area

  • 5.1. Key segment trends
  • 5.2. Oncology
    • 5.2.1. Market size, by region, 2013 - 2024
  • 5.3. Clinical pharmacology
    • 5.3.1. Market size, by region, 2013 - 2024
  • 5.4. Cardiology
    • 5.4.1. Market size, by region, 2013 - 2024
  • 5.5. Infectious disease
    • 5.5.1. Market size, by region, 2013 - 2024
  • 5.6. Neurology
    • 5.6.1. Market size, by region, 2013 - 2024
  • 5.7. Gastroenterology & hepatology
    • 5.7.1. Market size, by region, 2013 - 2024
  • 5.8. Ophthalmology
    • 5.8.1. Market size, by region, 2013 - 2024
  • 5.9. Others
    • 5.9.1. Market size, by region, 2013 - 2024

Chapter 6. Contract Research Organization Market, By End-use

  • 6.1. Key segment trends
  • 6.2. Pharmaceutical & biopharmaceutical companies
    • 6.2.1. Market size, by region, 2013 - 2024
  • 6.3. Medical device companies
    • 6.3.1. Market size, by region, 2013 - 2024
  • 6.4. Academic institutes
    • 6.4.1. Market size, by region, 2013 - 2024

Chapter 7. Contract Research Organization Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country 2013 - 2024
    • 7.2.2. Market size, by service type, 2013 - 2024
      • 7.2.2.1. Market size, by early phase development services, 2013 - 2024
        • 7.2.2.1.1. Market size, by pre-clinical services, 2013 - 2024
      • 7.2.2.2. Market size, by clinical research services, 2013 - 2024
      • 7.2.2.3. Market size, by laboratory services, 2013 - 2024
        • 7.2.2.3.1. Market size, by analytical testing services, 2013 - 2024
    • 7.2.3. Market size, by therapeutic area, 2013 - 2024
    • 7.2.4. Market size, by end-use, 2013 - 2024
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by service type, 2013 - 2024
        • 7.2.5.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.2.5.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.2.5.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.2.5.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.2.5.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.2.5.2. Market size, by therapeutic area, 2013 - 2024
      • 7.2.5.3. Market size, by end-use, 2013 - 2024
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by service type, 2013 - 2024
        • 7.2.6.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.2.6.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.2.6.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.2.6.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.2.6.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.2.6.2. Market size, by therapeutic area, 2013 - 2024
      • 7.2.6.3. Market size, by end-use, 2013 - 2024
  • 7.3. Europe
    • 7.3.1. Market size, by country 2013 - 2024
    • 7.3.2. Market size, by service type, 2013 - 2024
      • 7.3.2.1. Market size, by early phase development services, 2013 - 2024
        • 7.3.2.1.1. Market size, by pre-clinical services, 2013 - 2024
      • 7.3.2.2. Market size, by clinical research services, 2013 - 2024
      • 7.3.2.3. Market size, by laboratory services, 2013 - 2024
        • 7.3.2.3.1. Market size, by analytical testing services, 2013 - 2024
    • 7.3.3. Market size, by therapeutic area, 2013 - 2024
    • 7.3.4. Market size, by end-use, 2013 - 2024
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by service type, 2013 - 2024
        • 7.3.5.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.3.5.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.3.5.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.3.5.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.3.5.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.3.5.2. Market size, by therapeutic area, 2013 - 2024
      • 7.3.5.3. Market size, by end-use, 2013 - 2024
    • 7.3.6. France
      • 7.3.6.1. Market size, by service type, 2013 - 2024
        • 7.3.6.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.3.6.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.3.6.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.3.6.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.3.6.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.3.6.2. Market size, by therapeutic area, 2013 - 2024
      • 7.3.6.3. Market size, by end-use, 2013 - 2024
    • 7.3.7. UK
      • 7.3.7.1. Market size, by service type, 2013 - 2024
        • 7.3.7.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.3.7.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.3.7.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.3.7.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.3.7.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.3.7.2. Market size, by therapeutic area, 2013 - 2024
      • 7.3.7.3. Market size, by end-use, 2013 - 2024
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by service type, 2013 - 2024
        • 7.3.8.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.3.8.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.3.8.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.3.8.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.3.8.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.3.8.2. Market size, by therapeutic area, 2013 - 2024
      • 7.3.8.3. Market size, by end-use, 2013 - 2024
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by service type, 2013 - 2024
        • 7.3.9.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.3.9.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.3.9.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.3.9.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.3.9.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.3.9.2. Market size, by therapeutic area, 2013 - 2024
      • 7.3.9.3. Market size, by end-use, 2013 - 2024
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country 2013 - 2024
    • 7.4.2. Market size, by service type, 2013 - 2024
      • 7.4.2.1. Market size, by early phase development services, 2013 - 2024
        • 7.4.2.1.1. Market size, by pre-clinical services, 2013 - 2024
      • 7.4.2.2. Market size, by clinical research services, 2013 - 2024
      • 7.4.2.3. Market size, by laboratory services, 2013 - 2024
        • 7.4.2.3.1. Market size, by analytical testing services, 2013 - 2024
    • 7.4.3. Market size, by therapeutic area, 2013 - 2024
    • 7.4.4. Market size, by end-use, 2013 - 2024
    • 7.4.5. Japan
      • 7.4.5.1. Market size, by service type, 2013 - 2024
        • 7.4.5.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.4.5.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.4.5.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.4.5.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.4.5.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.4.5.2. Market size, by therapeutic area, 2013 - 2024
      • 7.4.5.3. Market size, by end-use, 2013 - 2024
    • 7.4.6. India
      • 7.4.6.1. Market size, by service type, 2013 - 2024
        • 7.4.6.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.4.6.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.4.6.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.4.6.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.4.6.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.4.6.2. Market size, by therapeutic area, 2013 - 2024
      • 7.4.6.3. Market size, by end-use, 2013 - 2024
    • 7.4.7. China
      • 7.4.7.1. Market size, by service type, 2013 - 2024
        • 7.4.7.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.4.7.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.4.7.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.4.7.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.4.7.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.4.7.2. Market size, by therapeutic area, 2013 - 2024
      • 7.4.7.3. Market size, by end-use, 2013 - 2024
  • 7.5. Latin America
    • 7.5.1. Market size, by country 2013 - 2024
    • 7.5.2. Market size, by service type, 2013 - 2024
      • 7.5.2.1. Market size, by early phase development services, 2013 - 2024
        • 7.5.2.1.1. Market size, by pre-clinical services, 2013 - 2024
      • 7.5.2.2. Market size, by clinical research services, 2013 - 2024
      • 7.5.2.3. Market size, by laboratory services, 2013 - 2024
        • 7.5.2.3.1. Market size, by analytical testing services, 2013 - 2024
    • 7.5.3. Market size, by therapeutic area, 2013 - 2024
    • 7.5.4. Market size, by end-use, 2013 - 2024
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by service type, 2013 - 2024
        • 7.5.5.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.5.5.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.5.5.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.5.5.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.5.5.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.5.5.2. Market size, by therapeutic area, 2013 - 2024
      • 7.5.5.3. Market size, by end-use, 2013 - 2024
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by service type, 2013 - 2024
        • 7.5.6.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.5.6.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.5.6.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.5.6.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.5.6.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.5.6.2. Market size, by therapeutic area, 2013 - 2024
      • 7.5.6.3. Market size, by end-use, 2013 - 2024
  • 7.6. MEA
    • 7.6.1. Market size, by country 2013 - 2024
    • 7.6.2. Market size, by service type, 2013 - 2024
      • 7.6.2.1. Market size, by early phase development services, 2013 - 2024
        • 7.6.2.1.1. Market size, by pre-clinical services, 2013 - 2024
      • 7.6.2.2. Market size, by clinical research services, 2013 - 2024
      • 7.6.2.3. Market size, by laboratory services, 2013 - 2024
        • 7.6.2.3.1. Market size, by analytical testing services, 2013 - 2024
    • 7.6.3. Market size, by therapeutic area, 2013 - 2024
    • 7.6.4. Market size, by end-use, 2013 - 2024
    • 7.6.5. Saudi Arabia
      • 7.6.5.1. Market size, by service type, 2013 - 2024
        • 7.6.5.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.6.5.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.6.5.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.6.5.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.6.5.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.6.5.2. Market size, by therapeutic area, 2013 - 2024
      • 7.6.5.3. Market size, by end-use, 2013 - 2024
    • 7.6.6. South Africa
      • 7.6.6.1. Market size, by service type, 2013 - 2024
        • 7.6.6.1.1. Market size, by early phase development services, 2013 - 2024
        • 7.6.6.1.1.1. Market size, by pre-clinical services, 2013 - 2024
        • 7.6.6.1.2. Market size, by clinical research services, 2013 - 2024
        • 7.6.6.1.3. Market size, by laboratory services, 2013 - 2024
        • 7.6.6.1.3.1. Market size, by analytical testing services, 2013 - 2024
      • 7.6.6.2. Market size, by therapeutic area, 2013 - 2024
      • 7.6.6.3. Market size, by end-use, 2013 - 2024

Chapter 8. Company Profiles

  • 8.1. Charles River Laboratories International, Inc. (CRL)
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Clinipace
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Clinitec
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. CMIC Holdings Co., Ltd
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. EPS International
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. ICON Public Limited Corporation
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Laboratory Corporation of America Holdings (Covance Inc.)
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. Medpace, Inc.
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Parexel International Corporation
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Pharmaceutical Product Development (PDD), LLC.
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. PRA Health Sciences
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. IQVIA (Quintiles IMS Holdings, Inc.)
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis
  • 8.13. Syneos Health
    • 8.13.1. Business overview
    • 8.13.2. Financial data
    • 8.13.3. Product landscape
    • 8.13.4. Strategic outlook
    • 8.13.5. SWOT analysis
  • 8.14. Synteract
    • 8.14.1. Business overview
    • 8.14.2. Financial data
    • 8.14.3. Product landscape
    • 8.14.4. Strategic outlook
    • 8.14.5. SWOT analysis
  • 8.15. Worldwide Clinical Trials
    • 8.15.1. Business overview
    • 8.15.2. Financial data
    • 8.15.3. Product landscape
    • 8.15.4. Strategic outlook
    • 8.15.5. SWOT analysis
  • 8.16. Wuxi AppTec
    • 8.16.1. Business overview
    • 8.16.2. Financial data
    • 8.16.3. Product landscape
    • 8.16.4. Strategic outlook
    • 8.16.5. SWOT analysis
Back to Top